EcoDrugPlus

Adenosine A2b Receptor

Ensembl ID : ENSDCDG00000011662
Gene Symbol: ADORA2B
3 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSDCDG00000017893
Gene Symbol: ADORA3
3 Cross references
128 Possible Orthologues:

Adenosine Deaminase-Like

Ensembl ID : ENSDCDG00000022311
Gene Symbol: LOC114798138
3 Cross references
219 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSDCDG00000016758
Gene Symbol: LOC114801159
2 Cross references
236 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSDCDG00000016788
Gene Symbol: LOC114798273
3 Cross references
201 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSDCDG00000027605
Gene Symbol: ADRM1
3 Cross references
198 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSDCDG00000032667
Gene Symbol: ADRA1B
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSDCDG00000014268
Gene Symbol: ADRA1D
3 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSDCDG00000005618
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSDCDG00000003851
Gene Symbol: ADRA2B
1 Cross references
211 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSDCDG00000027977
Gene Symbol: ADRA2C
1 Cross references
161 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSDCDG00000017738
Gene Symbol: ADRA2C
1 Cross references
156 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).